These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1699282)

  • 1. A comprehensive phase I and II clinical investigation of fludarabine phosphate.
    Grever M; Leiby J; Kraut E; Metz E; Neidhart J; Balcerzak S; Malspeis L
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):39-48. PubMed ID: 1699282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
    Binet JL
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I clinical trials with fludarabine phosphate.
    Von Hoff DD
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):33-8. PubMed ID: 1699281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues for the future development of fludarabine phosphate.
    Cheson BD
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):71-8. PubMed ID: 1699286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
    Gershanovich ML; Zaritskiĭ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA
    Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
    Arima N; Mizoguchi H; Shirakawa S; Tomonaga M; Takatsuki K; Ohno R
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
    Keating MJ
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):49-62. PubMed ID: 1699283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fludarabine phosphate--looking forward.
    Cheson BD
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract]   [Full Text] [Related]  

  • 10. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine phosphate therapy of non-Hodgkin's lymphoma.
    Hochster H; Cassileth P
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):63-5. PubMed ID: 1699284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
    Chun HG; Leyland-Jones B; Cheson BD
    J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine phosphate therapy in other lymphoid malignancies.
    Kantarjian HM; Redman JR; Keating MJ
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
    Rodriguez G
    Invest New Drugs; 1994; 12(2):75-92. PubMed ID: 7532163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.
    Malspeis L; Grever MR; Staubus AE; Young D
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):18-32. PubMed ID: 1699279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
    Redman JR; Cabanillas F; Velasquez WS; McLaughlin P; Hagemeister FB; Swan F; Rodriguez MA; Plunkett WK; Keating MJ
    J Clin Oncol; 1992 May; 10(5):790-4. PubMed ID: 1373760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.
    Avramis VI; Champagne J; Sato J; Krailo M; Ettinger LJ; Poplack DG; Finkelstein J; Reaman G; Hammond GD; Holcenberg JS
    Cancer Res; 1990 Nov; 50(22):7226-31. PubMed ID: 1699658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
    Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
    Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
    J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
    Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
    J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.